The Environmental Impact of Pharmaceuticals on Water

Clicks: 1
ID: 338499
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #1,783 of 1,787 articles by views in Oxford University Press eBooks

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,787 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract The global pharmaceutical industry plays a vital role in modern health care, yet it poses significant environmental and ethical challenges, particularly concerning water resource management and pollution. Pharmaceuticals enter the environment not only through manufacturing processes but also through human and animal excretion, with active pharmaceutical ingredients excreted and polluting water systems worldwide. These issues disproportionately impact lower-income countries, where pharmaceutical manufacturing in water-stressed regions exacerbates environmental injustice. Local communities bear the brunt of ecological harm while developed nations benefit from cheaper medicines, raising ethical dilemmas around balancing global health benefits with environmental degradation. Antimicrobial resistance further compounds these challenges, representing a “tragedy of the commons” that threatens global health, eco-systems, and economic stability. Addressing these issues requires interdisciplinary collaboration and integrated bioethics that consider both environmental and medical ethics. Ethical solutions must balance consequentialist and deontological concerns, emphasize collective responsibility and equitable resource distribution, and account for the rights and responsibilities among humans, animals, and the environment as a path forward. Ultimately, the integration of environmental sustainability into pharmaceutical practices is critical to mitigating ecological harm, ensuring public health, and safeguarding economic stability for future generations.
Reference Key
openalex_W7225197015 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mark Knight
Are you one of these authors? Claim your profile
Journal Oxford University Press eBooks
Year 2026
DOI
10.1093/9780197807262.003.0025
URL
https://doi.org/10.1093/9780197807262.003.0025
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.